O VIVANI Trademark

Trademark Overview


On Thursday, July 28, 2022, a trademark application was filed for O VIVANI with the United States Patent and Trademark Office. The USPTO has given the O VIVANI trademark a serial number of 97523882. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Wednesday, August 14, 2024. This trademark is owned by Second Sight Medical Products, Inc.. The O VIVANI trademark is filed in the Chemical Products, Pharmaceutical Products, and Medical Instrument Products categories with the following description:

Implantable drug delivery devices having a drug reservoir filled with pharmaceutical preparations and a nanoporous membrane for improving medication adherence in the treatment of chronic disease, in particular, metabolic diseases, namely, diabetes, obesity or non-alcoholic steatohepatits, and psychological diseases, namely, Alzheimer's, dementia, sociopathy or psychopathy; Implantable drug delivery devices having a drug reservoir and a nanoporous membrane sold preloaded with a therapeutic agent, namely, an injectable device for time release of the therapeutic agent for improving medication adherence in the treatment of chronic disease, in particular, metabolic diseases, namely, diabetes, obesity or non-alcoholic steatohepatits, and psychological diseases, namely, Alzheimer's, dementia, sociopathy or psychopathy

Nanoporous membranes used in drug delivery devices for controlling the rate of release of the subject therapeutic compound by selecting nano-pores slightly larger than the molecular diameter of the therapeutic compound; Nanoporous membranes used for controlling the rate of release of the subject therapeutic compound by selecting nano-pores slightly larger than the molecular diameter of the therapeutic compound that control the amount and rate of drug released from a drug implant where the drug reservoir dictates the duration of therapy delivered from the drug implant

Nanoporous membranes used in drug delivery devices for improving medication adherence in the treatment of chronic disease, in particular, metabolic diseases, namely, diabetes, obesity or non-alcoholic steatohepatits, and psychological diseases, namely, Alzheimer's, dementia, sociopathy or psychopathy; miniature long-term drug implants utilizing proprietary implantable drug delivery technology; nanoporous membranes used for improving medication adherence in the treatment of chronic disease, in particular, metabolic diseases, namely, diabetes, obesity or non-alcoholic steatohepatits, and psychological diseases, namely, Alzheimer's, dementia, sociopathy or psychopathy that control the amount and rate of drug released from a drug implant where the drug reservoir dictates the duration of therapy delivered from the drug implant for treatment of metabolic diseases, namely, diabetes, obesity or non-alcoholic steatohepatits, and psychological diseases, namely, Alzheimer's, dementia, sociopathy ...
o vivani

General Information


Serial Number97523882
Word MarkO VIVANI
Filing DateThursday, July 28, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateWednesday, August 14, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 20, 2023

Trademark Statements


Description of MarkThe mark consists of the wording "Vivani" with an arch of spheres with a stylized O at the top, where the arch of spheres start at the dot of the first "i" in "Vivani" and ends at the dot of the second "i" in "Vivani", all in aqua green.
Goods and ServicesImplantable drug delivery devices having a drug reservoir filled with pharmaceutical preparations and a nanoporous membrane for improving medication adherence in the treatment of chronic disease, in particular, metabolic diseases, namely, diabetes, obesity or non-alcoholic steatohepatits, and psychological diseases, namely, Alzheimer's, dementia, sociopathy or psychopathy; Implantable drug delivery devices having a drug reservoir and a nanoporous membrane sold preloaded with a therapeutic agent, namely, an injectable device for time release of the therapeutic agent for improving medication adherence in the treatment of chronic disease, in particular, metabolic diseases, namely, diabetes, obesity or non-alcoholic steatohepatits, and psychological diseases, namely, Alzheimer's, dementia, sociopathy or psychopathy
Indication of Colors claimedThe color(s) aqua green is/are claimed as a feature of the mark.
Goods and ServicesNanoporous membranes used in drug delivery devices for controlling the rate of release of the subject therapeutic compound by selecting nano-pores slightly larger than the molecular diameter of the therapeutic compound; Nanoporous membranes used for controlling the rate of release of the subject therapeutic compound by selecting nano-pores slightly larger than the molecular diameter of the therapeutic compound that control the amount and rate of drug released from a drug implant where the drug reservoir dictates the duration of therapy delivered from the drug implant
Goods and ServicesNanoporous membranes used in drug delivery devices for improving medication adherence in the treatment of chronic disease, in particular, metabolic diseases, namely, diabetes, obesity or non-alcoholic steatohepatits, and psychological diseases, namely, Alzheimer's, dementia, sociopathy or psychopathy; miniature long-term drug implants utilizing proprietary implantable drug delivery technology; nanoporous membranes used for improving medication adherence in the treatment of chronic disease, in particular, metabolic diseases, namely, diabetes, obesity or non-alcoholic steatohepatits, and psychological diseases, namely, Alzheimer's, dementia, sociopathy or psychopathy that control the amount and rate of drug released from a drug implant where the drug reservoir dictates the duration of therapy delivered from the drug implant for treatment of metabolic diseases, namely, diabetes, obesity or non-alcoholic steatohepatits, and psychological diseases, namely, Alzheimer's, dementia, sociopathy or psychopathy, and other diseases treated with small drug molecules; Electrotherapy medical devices for electrical nerve stimulation and recording, namely, neurostimulation devices, stimulating and recording electrode implants, visual prostheses and visual cortical implants; Cortical electrodes integrally attached to implantable cortical stimulators and other systems, namely, electrodes, stimulators, headpieces, and wearable video processors for the treatment of blindness; Surgical apparatus and instruments for the treatment of blindness; Medical apparatus and instruments for use in surgery for the treatment of blindness; Medical devices for the treatment of blindness

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateSaturday, May 13, 2023
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, May 13, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, August 19, 2022
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameVIVANI MEDICAL, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressALAMEDA, CA 94502

Party NameSecond Sight Medical Products, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressValenica, CA 91355

Party NameSecond Sight Medical Products, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSylmar, CA 91342

Trademark Events


Event DateEvent Description
Monday, August 1, 2022NEW APPLICATION ENTERED
Friday, August 19, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, August 20, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, February 13, 2023ASSIGNED TO EXAMINER
Tuesday, February 14, 2023NON-FINAL ACTION WRITTEN
Tuesday, February 14, 2023NON-FINAL ACTION E-MAILED
Tuesday, February 14, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, May 12, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, May 12, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, May 13, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 18, 2023EXAMINERS AMENDMENT -WRITTEN
Thursday, May 18, 2023EXAMINERS AMENDMENT E-MAILED
Thursday, May 18, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, May 18, 2023EXAMINER'S AMENDMENT ENTERED
Thursday, May 18, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 31, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 20, 2023PUBLISHED FOR OPPOSITION
Tuesday, June 20, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 15, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, February 7, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, February 7, 2024SOU EXTENSION 1 FILED
Wednesday, February 7, 2024SOU EXTENSION 1 GRANTED
Friday, February 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 14, 2024SOU TEAS EXTENSION RECEIVED
Thursday, August 15, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 15, 2024SOU EXTENSION 2 GRANTED
Thursday, August 15, 2024SOU EXTENSION 2 FILED
Friday, February 14, 2025TEAS STATEMENT OF USE RECEIVED
Wednesday, February 21, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP